Bracco Diagnostics signs MRI contrast media agreement

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

Imaging agent manufacturer Bracco Diagnostics of Princeton, N.J., and HealthTrust Purchasing Group of Brentwood, Tenn., have signed a three-year agreement that will make Bracco Imaging SpA’s MRI contrast media products available to HealthTrust members. 

HealthTrust Purchasing Group supports more than 1,300 not-for-profit and for-profit acute care hospitals, 430 ambulatory surgery centers, nearly 2,500 physician practices, as well as over 3,000 alternate care sites.
The agreement, which was effective Sept. 1 and extends through Aug. 31, 2010, includes 529 mg/mL of MultiHance injection and 279.3 mg/mL of ProHance injection, according to Bracco.